Literature DB >> 15072324

A comparative study of clinico-radiological spectrum of tuberculosis among HIV seropositive and HIV seronegative patients.

R Prasad1, J K Saini, R Gupta, R K Kannaujia, S Sarin, R Kulshreshth, V L Nag, A K Tripathi.   

Abstract

BACKGROUND: A study to determine the prevalence of human immunodeficiency virus (HIV) infection among tuberculosis patients and to compare the clinico-radiological spectrum of tuberculosis among HIV seropositive and seronegative patients was carried out in the Department of TB and Chest Diseases, CSM Medical University, Lucknow (Uttar Pradesh), India.
METHODS: A total of 1105 radiologically and/or bacteriologically confirmed patients of tuberculosis were screened for HIV infection during the years 1995 to 1997 and from 2000-2001.
RESULTS: Out of a total 1105 patients screened, 31(2.8%) were found to be HIV seropositive. Tuberculin positivity was less among HIV seropositive patients as compared to HIV seronegative patients (22.6% vs 76.4%; p < 0.001). There was no statistically significant difference in sputum smear positivity for acid-fast bacilli (AFB) among HIV seropositive and seronegative patients. Among HIV seropositive patients, mid and lower zone involvement, exudative lesions and mediastinal lymphadenopathy was more common as compared to the seronegative patients.
CONCLUSION: HIV seropositivity rates among tuberculosis patients was 2.8 percent. The presentation of tuberculosis was more often atypical among these patients.

Entities:  

Mesh:

Year:  2004        PMID: 15072324

Source DB:  PubMed          Journal:  Indian J Chest Dis Allied Sci        ISSN: 0377-9343


  2 in total

1.  Clinico-epidemiological profile of HIV/TB coinfected patients in Vadodara, Gujarat.

Authors:  Ragini Ghiya; Eknath Naik; Beata Casanas; Ricardo Izurieta; Yogesh Marfatia
Journal:  Indian J Sex Transm Dis AIDS       Date:  2009-01

2.  Pulmonary Tuberculosis in Patients with HIV/AIDS in Iran.

Authors:  A Hadadi; P Tajik; M Rasoolinejad; S Davoudi; M Mohraz
Journal:  Iran J Public Health       Date:  2011-03-31       Impact factor: 1.429

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.